Human papillomavirus type 16 E1 E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexes.
about
The E1circumflexE4 protein of human papillomavirus interacts with the serine-arginine-specific protein kinase SRPK1Suppression of Vimentin Phosphorylation by the Avian Reovirus p17 through Inhibition of CDK1 and Plk1 Impacting the G2/M Phase of the Cell CycleDownregulation of Cdc2/CDK1 kinase activity induces the synthesis of noninfectious human papillomavirus type 31b virions in organotypic tissues exposed to benzo[a]pyrene.Human papillomavirus type 16 E1circumflexE4 contributes to multiple facets of the papillomavirus life cycle.A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers.E4 antibodies facilitate detection and type-assignment of active HPV infection in cervical diseaseCD66+ cells in cervical precancers are partially differentiated progenitors with neoplastic traitsHuman papillomavirus type 1 E1^E4 protein is a potent inhibitor of the serine-arginine (SR) protein kinase SRPK1 and inhibits phosphorylation of host SR proteins and of the viral transcription and replication regulator E2Human herpesvirus 6 suppresses T cell proliferation through induction of cell cycle arrest in infected cells in the G2/M phase.Role of calpain in the formation of human papillomavirus type 16 E1^E4 amyloid fibers and reorganization of the keratin network.Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCMThe Replicative Consequences of Papillomavirus E2 Protein Binding to the Origin Replication Factor ORC2HPV16 and 18 genome amplification show different E4-dependence, with 16E4 enhancing E1 nuclear accumulation and replicative efficiency via its cell cycle arrest and kinase activation functions.Human papillomavirus type 16 E5 protein as a therapeutic target.Human papillomavirus E7 induces rereplication in response to DNA damagePhosphorylation of the human papillomavirus type 16 E1--E4 protein at T57 by ERK triggers a structural change that enhances keratin binding and protein stabilityNovel inhibitors of Rad6 ubiquitin conjugating enzyme: design, synthesis, identification, and functional characterization.Human papillomaviruses: a growing fieldChlamydia trachomatis infection induces cleavage of the mitotic cyclin B1E6/E7 oncogenes in epithelial suprabasal layers and estradiol promote cervical growth and ear regeneration.Minute Virus of Mice Inhibits Transcription of the Cyclin B1 Gene during Infection.Human papillomavirus 18 E1^E4 protein interacts with cyclin A/CDK 2 through an RXL motif.Keratinocyte Differentiation-Dependent Human Papillomavirus Gene Regulation.Mechanisms by which HPV Induces a Replication Competent Environment in Differentiating Keratinocytes.HPV18 E1^E4 is assembled into aggresome-like compartment and involved in sequestration of viral oncoproteins.Potential Role of E4 Protein in Human Papillomavirus Screening: a ReviewRole for Wee1 in inhibition of G2-to-M transition through the cooperation of distinct human papillomavirus type 1 E4 proteins.Host cell transcriptome modification upon exogenous HPV16 L2 protein expression.Protoparvovirus Interactions with the Cellular DNA Damage Response.Mutations in HPV18 E1^E4 Impact Virus Capsid Assembly, Infectivity Competence, and Maturation.Molecular and phylogenetic analysis of the HPV 16 E4 gene in cervical lesions from women in Greece.Regulation of the human papillomavirus type 16 late promoter by E7 and the cell cycle.
P2860
Q24300233-66CBE6F2-875E-4C8B-A7E6-9D4AB766EDB2Q28388816-100DD46B-387B-4DC5-B9C0-428671054E47Q33826637-21981271-3EC4-48E6-B2F1-49C909E36DECQ34045582-B990F724-257C-4E6B-9F82-7D79238B1586Q34121681-E2C26EEE-34CE-4EC1-93B5-D89144294FE2Q34506439-6135FC02-B4A6-4DBB-A56F-89BD5CB37F6AQ34518394-70840163-4617-424D-AD2C-2AD332B95785Q34593811-8E63FBAD-EC41-4C20-A7D9-9D20520EAB9FQ35077591-0AC3639A-CBB8-4857-93D3-C198B7EBB9B6Q35382591-208C8629-DB67-4412-8269-C88EC064C2B8Q35811067-2413EFF5-E841-4905-B8E8-DD115E46373DQ36152782-A46D5EFE-163A-4B36-B4F2-BDC4EBB37E22Q36312170-FE477E98-88F5-481A-8055-759733BA7BECQ36406751-3B64F56C-06A6-4958-ACCE-9CD236735D94Q36559551-C4AC51DF-21B8-415D-8974-AFBD8A580247Q37145237-A7B71CB2-F783-4871-9060-C057803457E7Q37343840-FC38BC43-2ABE-4CE4-A884-8412BC7177E5Q37390871-53606A27-5921-4761-9CF9-373C8E670327Q37861412-DEBA3A57-8D85-49AA-81ED-1BE04EB3A1B5Q38605935-BF9B28DE-AC4A-44E1-B820-687A9B835715Q38705905-49D48416-296E-4CB2-B6B9-49A74584F7ADQ39259475-A9F041B4-4E04-47C6-BB07-C9D18C74B2FEQ40059698-885DE9EB-5D44-4E1F-964A-D8B7A53F35B4Q41669449-31AD8422-398C-4A01-A9C6-5A77918C679EQ42066953-31942AF9-7696-46CA-9642-1326B9C4A689Q42343538-D12F2B02-775A-4EED-A02A-3FFB2DBF2BC3Q42730958-42415667-3057-4E6F-AD9E-42FD132908B3Q45943269-3C84AE4A-F607-403F-B0F3-AF5077728432Q46271543-FA0F4C03-0D5E-40FE-BA26-D9B37D472DC2Q47108460-72D4CDDB-BE75-4DA9-8036-599CD900AA6DQ48048969-324F8201-11B5-4046-AB6D-2FBB240823FDQ50238227-8C994BF6-221B-4CC5-B988-230261D17098
P2860
Human papillomavirus type 16 E1 E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexes.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Human papillomavirus type 16 E ...... tive Cdk1/cyclin B1 complexes.
@ast
Human papillomavirus type 16 E ...... tive Cdk1/cyclin B1 complexes.
@en
type
label
Human papillomavirus type 16 E ...... tive Cdk1/cyclin B1 complexes.
@ast
Human papillomavirus type 16 E ...... tive Cdk1/cyclin B1 complexes.
@en
prefLabel
Human papillomavirus type 16 E ...... tive Cdk1/cyclin B1 complexes.
@ast
Human papillomavirus type 16 E ...... tive Cdk1/cyclin B1 complexes.
@en
P2093
P2860
P1433
P1476
Human papillomavirus type 16 E ...... tive Cdk1/cyclin B1 complexes.
@en
P2093
Clare E Davy
Deborah J Jackson
John Doorbar
Jonathan B A Millar
Kate Middleton
Kenneth Raj
Paul F Lambert
Peter Laskey
Phillip J Masterson
P2860
P304
P356
10.1128/JVI.79.7.3998-4011.2005
P577
2005-04-01T00:00:00Z